ANXA2 and liver cancer: Thus, it is speculated that the methylation of Annexin A2 gene promoter in liver cells may inhibit Annexin A2 expression, reduce the storage of HBsAg, and decrease the risk of liver cancer, which may be the body’s own defence mechanism.